RAPT Therapeutics, Inc. announced the addition of Wendye Robbins, M.D., president and CEO of Blade Therapeutics, Inc., to the company’s board of directors. Dr. Robbins brings 20 years of experience as an executive leading and advising innovative biotechnology companies through all stages of development. Dr. Robbins has also served on the faculty at Stanford University School of Medicine in the Department of Anesthesia, Perioperative Care, and Pain Medicine since 2004.